MONOCLONAL-TYPE SYNTHETIC ANTIBODIES OBTAINED BY MOLECULAR IMPRINTING AND THEIR USE FOR THE TREATMENT AND PREVENTIVE MEDICINE OF COVID-19

摘要

Monoclonal-type synthetic antibodies, produced by Molecular Imprinting, capable of specifically recognizing and binding the receptor-binding domain (RBD) of Subunit S1 and/or Subunit S2 of SARS-CoV-2 Spike Protein, in which the receptor-binding domain RBD is responsible for host cell receptor recognition and binding, while Subunit S2 is involved in the viral and host membranes fusion.